From an outbreak signal to a whole genome
Investigating CV-A24v in Islamabad—and what the experience taught me about connecting specimen quality, metagenomic analysis, reference choice, and cautious interpretation.
The unresolved question
Outbreak genomics often begins before the causative agent is clear.
In September 2023, conjunctivitis cases in Islamabad created a practical diagnostic and surveillance problem. Clinical presentation indicated acute haemorrhagic conjunctivitis, but a suitable targeted test was not readily available to identify the viral cause. The available eye-swab specimens also presented the familiar constraints of low viral RNA, variable starting material, and background nucleic acid.
The task was therefore broader than running a sequencing protocol. We needed an evidence chain capable of moving from a difficult clinical specimen to a defensible genomic interpretation.
Why the routine approach was insufficient
Metagenomic sequencing can detect signals beyond a predefined target panel, but a taxonomic label is not automatically a confirmed result. Low-complexity reads, host background, incomplete reference databases, closely related viruses, and uneven genome coverage can all produce a plausible-looking answer that does not survive deeper review.
The laboratory and computational stages could not be treated as separate services. Poor recovery at the specimen or library stage would limit every downstream analysis. At the same time, an apparently strong classifier result still needed genome-wide support, comparison with close relatives, and phylogenetic context.
My contribution
My work crossed the wet-lab and bioinformatics parts of the investigation.
At the specimen and library stages, I compared extraction approaches and different starting inputs from eye-swab material to improve viral RNA recovery. I also refined library cleanup to reduce adapter dimers and remove unsuitable fragments that could compromise sequencing output.
At the analysis stage, I evaluated alternative approaches rather than relying on one classifier. I worked on improving the reference databases and pathogen-discovery workflow used to distinguish meaningful viral evidence from background signals. Candidate findings were considered alongside sequence searches, mapping support, genome coverage, close-relative comparisons, phylogenetic placement, and mutation analysis.
This was not a linear process in which the laboratory produced data and the computer supplied an answer. Evidence from one stage informed the next decision, and weak points had to remain visible.
From candidate signal to supported finding
The published study examined specimens from the 2023 outbreak and applied metagenomic next-generation sequencing to a subset collected early after symptom onset. Coxsackievirus A24 variant was detected in three sequenced samples and was classified as genotype IV.
Whole-genome and phylogenetic analysis placed the outbreak sequences in the context of contemporary and historical strains. The study also compared the 2023 sequences with those from an earlier Pakistan outbreak and reviewed amino-acid changes, including differences in the VP1 region.
The important point was not the first appearance of a taxonomic name in a results table. Confidence came from convergence across multiple forms of evidence: specimen context, read and contig evidence, genome-wide support, reference comparison, and evolutionary placement.
What this experience taught me
- Pathogen discovery is a complete workflow. No analytical tool can recover biological information lost through unsuitable starting material or poor library quality. Good sequencing output can still be misinterpreted when reference databases and confirmation rules are weak.
- Reference choice shapes the answer. Taxonomic coverage, redundancy, close relatives, and sequence quality affect which candidate appears strongest. Confirmation should compare plausible alternatives rather than map only to the first hit.
- Coverage distribution matters more than a read count alone. Breadth, depth, mapping quality, and genomic context belong together when deciding whether a signal is credible.
- Uncertainty should lead to an action. An unresolved signal should trigger a defined next step—repeat preparation, additional sequencing, targeted confirmation, reference review, or a report that clearly states the limitation.
- Wet-lab and computational troubleshooting are one scientific skill. The useful question is often whether a weak signal originated in the specimen, extraction, library, run, reference set, or interpretation rule.
Turning the reasoning into a public artifact
I later translated this reasoning into a public-safe Pathogen Discovery and Confirmatory Mapping Pipeline. The workflow separates initial candidate screening from competitive confirmatory mapping and retains breadth, depth, and interpretation outputs for review.
It is not presented as a diagnostic system or as a replacement for laboratory confirmation. Its purpose is to make the analytical reasoning inspectable and reusable with public-safe demonstration data.
Questions I would take forward
- How should metagenomic and targeted approaches be combined when the causal agent is initially unknown?
- Which validation rules best distinguish a credible low-abundance signal from contamination, database artefact, or nonspecific mapping?
- How do specimen type, viral input, and library strategy change the practical sensitivity of pathogen-discovery workflows?
- Can public-safe benchmark mixtures and synthetic datasets make these decisions more comparable across laboratories?
- How can candidate-to-confirmation reporting be standardised without hiding scientific uncertainty?
These questions sit at the centre of the work I want to continue: integrating molecular methods and reproducible bioinformatics to detect viral threats earlier, interpret them cautiously, and make the resulting evidence useful in public-health settings.
Primary evidence
Haider SA, Jamal Z, Ammar M, et al. Genomic characterization of the Coxsackievirus A24 variant in the Acute Hemorrhagic Conjunctivitis outbreak (2023) in Islamabad, Pakistan through metagenomic next generation sequencing. Journal of Virological Methods. 2025;338:115213.